Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.39
-0.0700-4.79%
Volume:276.62K
Turnover:376.71K
Market Cap:83.09M
PE:-0.43
High:1.47
Open:1.47
Low:1.30
Close:1.46
Loading ...
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 29, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 27, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 22, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 22, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 21, 2023

Major Issues Report

8-K - Current report